Toxicity and neuronal infection of a HSV-1 ICP34.5 mutant in nude mice

Journal of NeuroVirology

Volumn 4, Issue 1, 1998, Pages 100-105

  Lasner, Todd M ^a,b   Tal Singer, Ruth ^b   Kesari, Santosh ^b,c   Lee, Virginia M Y ^c   Trojanowski, John Q ^c   Fraser, Nigel W ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Central nervous system; Herpes simplex virus; ICP34.5; Nude mouse; Replication; Toxicity

Indexed keywords

PROTEIN ICP34.5; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN HOMOGENATE; BRAIN NERVE CELL; BRAIN STEM; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; DEATH; DYING; EPENDYMA CELL; GENE DELETION; HERPES; HERPES SIMPLEX VIRUS; HIPPOCAMPUS; IMMUNE DEFICIENCY; MOUSE; NEOCORTEX; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; THALAMUS; VIRUS MUTANT; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TITRATION; VIRUS VIRULENCE;

EID: 0031915906     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289809113487     Document Type: Article

References (22)

1. Adams RL, Springall DR, Levene MM, Bushell TE (1984). The immunocytochemical detection of herpes simplex virus in cervical smears - a valuable technique for routine use. J Pathol 143: 241-247.
2. Brown SM, Harland J, MacLean AR, Podlech J, Clements JB (1994). Cell type and cell state determine differential in vitro growth of non-neurovirulent ICP34.5-negative herpes simplex virus types 1 and 2. J Gen Virol 75: 2367-2377.
3. Chambers R, Gillespie GY, Soroceanu L, Andreansky S, Chatterjee S, Chou J, Roizman B, Whitley RJ (1995). Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a seid mouse model of human malignant glioma. Proceedings of the National Academy of Sciences, USA 92: 1411-1415.
4. Chou J, Chen J-J, Gross M, Roizman B (1995). Association of a Mr 90,000 phosphoprotein with protein kinase PKR in cells exhibiting enhanced phosphorylation of translation initiation factor eIF2α and premature shutoff of protein synthesis after infection with γ34.5- mutants of herpes simplex virus 1. Proc Natl Acad Sci USA 92: 10516-10520.
5. Chou J, Kern ER, Whitlev RJ, Rouzman B (1990). Mapping of herpes simplex virus neurovirulence to gamma 1 34.5, a gene nonessential for growth in culture. Science 252: 1262-1266.
6. Chou J, Roizman B (1994). Herpes simplex virus 1 γ134.5 gene function, which blocks the host response to infections, maps in the homologous domain of the genes expressed during growth arrest and DNA damage. Proc Natl Acad Sci USA 91: 5247-5251.
7. - herpes simplex virus 1: failure of activated RNA-dependant protein kinase to shut off protein synthesis is associated with a deletion in the domain of the α47 gene. J Virol 71: 6049-6054.
8. Kesari S, Lee VM-Y, Brown SM, Trojanowski JQ, Fraser NW (1996). Selective vulnerability of mouse CNS neurons to latent infection with a neuroattenuated herpes simplex virus-1. The Journal of Neuroscience 16: 5644-5663.
9. Kesari S, Randazzo BP, Valyi-Nagy T, Huang QS, Brown SM, MacLean AR, Lee VM-Y, Trojanowski JQ, Fraser NW (1995). Therapy of experimental human brain tumors using a neuroattenuated herpes simplex virus mutant. Lab Invest 73: 636-648.
10. Lasner TM, Kesari S, Brown SM, Lee VM-Y, Fraser NW, Trojanowski JQ (1996). Therapy of a murine model of pediatric brain tumors using a herpes simplex virus type-1 ICP34.5 mutant and demonstration of viral replication within the CNS. J Neuropath Exp Neurol 55: 1259-1269.
11. MacLean AR, Ul-Fareed M, Robertson L, Harland J, Brown SM (1991). Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the 'a' sequence. J Gen Virol 72: 631-639.
12. Markert JM, Malick A, Coen DM, Martuza RL (1993). Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir. Neurosurgery 32: 597-603.
13. - mutant of herpes simplex virus 1. J Virol 71: 5560-5569.
14. McGeoch DJ, Dalrymple MA, Davison AJ, Dolan A, Frame MC, McNab D, Perry LJ, Scott JE, Taylor P (1988). The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol 69: 1531-1574.
15. Mohr I, Gluzman Y 1996). A herpes virus genetic element which affects translation in the absence of the viral GADD 34 function. EMBO J 15: 4759-4766.
16. Mineta T, Rabkin SD, Yazaki T, Hunter WD. Martuza RL (1995). Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nature Med 1: 938-943.
17. Perng G-C, Chokephaibulkit K, Thompson RL, Sawtell NM, Slanina SM, Ghiasi H, Nesburn AB, Wechsler SL (1996). The region of the herpes simplex virus type 1 LAT gene that is colinear with the ICP34.5 gene is not involved in spontaneous reactivation. J Virol 70: 282-291.
18. Pignatti PF, Cassai E, Meneguzzi G, Chenciner N, Milanesi G (1979). Herpes simplex virus DNA isolation from infected cells with a novel procedure. Virology 93: 260-264.
19. Tal-Singer R, Lasner TM, Podrzucki W, Skokotas A, Leary JJ, Berger SL, Fraser NW (1997). Gene expression during reactivation of herpes simplex virus type 1 from latency in the peripheral nervous system is different from that during lytic infection of tissue cultures. J Virol 71: 5268-5276.
20. Thompson RL, Stevens JG (1983). Biological characterization of a herpes simplex virus intertypic recombinant which is completely and specifically non-neurovirulent. Virology 131: 171-179.
21. Valyi-Nagy T, Deshmane SL, Raengsakulrach B, Nicosia M, Cesser RM, Wysocka M, Dillner A, Fraser NW (1992). Herpes simplex Virus type 1 mutant strain in1814 establishes a unique, slowly progressing infection in SCID mice. J Virol 66: 7336-7345.
22. Valyi-Nagy T, Cesser RM, Raengsakulrach B, Deshmane SL, Randazzo BP, Dillner AJ, Fraser NW (1994). A thymidine kinase-negative HSV-1 strain establishes a persistent infection in SCID mice that features uncontrolled peripheral replication but only marginal nervous system involvement. Virology 199: 484-490.